Non-Cystic Fibrosis Bronchiectasis
What is Non-Cystic Fibrosis Bronchiectasis?
Non-Cystic Fibrosis Bronchiectasis is a chronic, life-threatening condition that causes the lungs' airways to permanently widen. Symptoms include chronic cough, excessive sputum production, shortness of breath, wheezing, fatique, chest pain, and recurrent respiratory infections.
Treatments for Non-Cystic Fibrosis Bronchiectasis include airway clearance techniques, taking medications and oxygen therapy. Drug classes commonly used to treat it include DPP1-Inhibitors, corticosteroids, antibiotics, mucus thinners, and bronchodilators.
Popular Non-Cystic Fibrosis Bronchiectasis Drugs
Note: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Non-Cystic Fibrosis Bronchiectasis: Drug Classes
Non-Cystic Fibrosis Bronchiectasis drugs are grouped into the following classes based on how they work:
DPP-1 Inhibitors are used to treat inflammatory diseases caused by excessive neutrophil activity, including non-cystic fibrosis bronchiectasis. They work by binding to the DPP-1 enzyme and obstructing its activity, which reduces the activity of neutrophils.
Learn about DPP-1 Inhibitors